Astrazeneca AZN
NYSE AZN
$165.98 +1.49 (+0.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Astrazeneca (AZN) FCF Payout Ratio (2009 - 2026)

Astrazeneca (AZN) posted quarterly FCF Payout Ratio of 3.54 for Q2 2026, up 19.88% year-over-year from 2.95 in Q2 2025, and up 41.08% quarter-over-quarter from 6.01 in Q1 2026.

Astrazeneca (AZN) FCF Payout Ratio (2009 - 2026) Analysis & Trends

Astrazeneca's FCF Payout Ratio history runs 17 years deep, the most recent figure standing at 3.54 for Q2 2026.

  • In Q2 2026, FCF Payout Ratio rose 19.88% year-over-year to 3.54; the TTM figure through Jun 2026 stood at 1.62 (up 44.17% YoY), while the FY2025 annual figure was 0.31, down 5.6% from the prior year.
  • FCF Payout Ratio for Q2 2026 stood at 3.54, up from 6.01 in the prior quarter.
  • The five-year high for FCF Payout Ratio was 0.04 in Q2 2024, with the low at 13.57 in Q1 2022.
  • The 5-year median for FCF Payout Ratio is 3.78 (2024), against an average of 5.14.
  • The sharpest annual moves came in 2024 and 2025: FCF Payout Ratio soared 45.38% in 2024, then plunged 9830.31% in 2025.
  • Astrazeneca's FCF Payout Ratio stood at 13.57 in 2022, then jumped by 99.4% to 0.08 in 2023, then sank by 3517.33% to 2.95 in 2024, then increased by 26.44% to 2.17 in 2025, then sank by 63.3% to 3.54 in 2026.
  • Business Quant data shows AZN's FCF Payout Ratio at 3.54 in Q2 2026, 6.01 in Q1 2026, and 2.17 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 0.44
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 0.99
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 0.48
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 0.52
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -3.54
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 0.39
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 0.30
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 8.12
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.54
Mar 31, 2026 -6.01
Dec 31, 2025 -2.17
Sep 30, 2025 -2.91
Jun 30, 2025 -4.42
Mar 31, 2025 -7.80
Dec 31, 2024 -2.95
Sep 30, 2024 -3.78
Jun 30, 2024 -0.04
Mar 31, 2024 -7.27
Jun 30, 2023 -0.08
Mar 31, 2023 -12.34
Mar 31, 2022 -13.57
Dec 31, 2021 -4.15
Sep 30, 2021 -5.33
Mar 31, 2021 -11.22
Mar 31, 2020 -12.89
Sep 30, 2019 -5.49
Mar 31, 2019 11.42
Sep 30, 2018 -4.82